News Daily News Disparities in MCS Use for STEMI-Related Shock Seen Across the US Caitlin E. Cox October 21, 2025
News Daily News European Experts Provide Advice on Managing CV Effects of COVID-19 Todd Neale September 19, 2025
News Daily News Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s Michael O'Riordan September 18, 2025
News Daily News Half of Patients Stop Semaglutide for Weight Loss by 1 Year Todd Neale September 18, 2025
News Daily News AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review Todd Neale July 24, 2025
News Daily News Roughly Half of Patients Don’t Have Symptoms Prior to a First MI Todd Neale July 09, 2025
News Daily News AHA Offers Help for Clinicians Weighing the Results of DTC Genetic Tests Yael L. Maxwell March 18, 2025
News Daily News Newer Weight-Loss Drugs Not Cost-effective at Current Prices Michael O'Riordan March 18, 2025
News Daily News Better Cardiovascular Health May Stave Off Degenerative Brain Disease Todd Neale March 13, 2025
News Daily News CVD Hospitalization in Older Adults Higher in US Than in Denmark Michael O'Riordan February 07, 2025
News Daily News European Medicines Agency Investigating GLP-1 Drugs and Eye Disease L.A. McKeown January 21, 2025
News Daily News Athletes’ Hearts Also Require Careful Scrutiny, New Review Suggests Yael L. Maxwell January 17, 2025
News Daily News Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results Michael O'Riordan December 04, 2024
News Daily News Increased CVD Risk Seen Up to 30 Years Before Type 2 Diabetes Diagnosis Todd Neale November 28, 2024
News Daily News Weight-Loss Drug Tirzepatide Reduces Severity of Obstructive Sleep Apnea Michael O'Riordan June 25, 2024
News Daily News AF Patients Under Age 65 Have High Risk Factor Burden, More Adverse Outcomes Todd Neale April 26, 2024
News Daily News More Complications in Pregnancy Equals Higher Risk of ASCVD Mortality Caitlin E. Cox February 28, 2024